This study looks at how well the drug ibalizumab works for people with multidrug-resistant HIV in everyday medical practice. It compares patients who receive ibalizumab plus other HIV drugs to similar patients who do not receive ibalizumab. The goal is to understand long-term vir…
Sponsor: Theratechnologies • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC